+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Intelligence (AI) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, OBGY,MRI, CT, Ultrasound, IVD), End User (Hospital, Diagnostic Laboratory, Diagnostic Imaging Center)- Global Forecast to 2025

  • ID: 5315018
  • Report
  • April 2021
  • Region: Global
  • 167 Pages
  • Markets and Markets

FEATURED COMPANIES

  • Aidence
  • Enlitic
  • IBM
  • Microsoft Corporation
  • Quibim
  • Therapixel

The global AI in medical diagnostics market is projected to reach USD 3,868 million by 2025 from USD 505 million in 2020, at a CAGR of 50.2% during the forecast period. Growth in this market is primarily driven by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field, growing focus on reducing the workload of radiologists, influx of large and complex datasets, growth in funding for AI-based start-ups, and the growing number of cross-industry partnerships and collaborations. 




Software segment is expected to grow at the highest CAGR


On the basis of component, the AI in medical diagnostics market is segmented into software and services. The services segment dominated this market in 2020, while the software segment is estimated to grow at a higher CAGR during the forecast period. Software solutions help healthcare providers gain a competitive edge despite the challenges of being short-staffed and facing increasing imaging scan volumes. This is a key factor driving the growth of the software segment.


Hospitals to establish the largest market size of AI in medical diagnostics market


Based on end user, the AI in medical diagnostics market is segmented into hospitals, diagnostic imaging centers, diagnostic laboratories, and other end users. The hospitals segment commanded the largest share of 64.1% of this market in 2019. The large share of this segment can be attributed to the rising number of diagnostic imaging procedures performed in hospitals, the growing inclination of hospitals toward the automation and digitization of radiology patient workflow, increasing adoption of minimally invasive procedures in hospitals to improve the quality of patient care, and the rising adoption of advanced imaging modalities to improve workflow efficiency.


North America To Witness Significant Growth From 2020 to 2025


The AI in medical diagnostics market has been segmented into four main regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share of 37.6%. However, the APAC market is projected to register the highest CAGR of 53.2% during the forecast period, primarily due to the growth strategies adopted by companies in emerging markets, improved medical diagnostic infrastructure, increasing geriatric population, rising prevalence of cancer, and the implementation of favorable government initiatives.


Breakdown of supply-side primary interviews:


  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, Director-level - 18%, and Others - 55%
  • By Region: North America - 40%, Europe - 20%, APAC - 30%, Rest of the World - 10% 

Some of the prominent players operating in the AI in medical diagnostics market are Microsoft Corporation (US), NVIDIA (US), IBM (US), Intel (US), Siemens Healthineers (Germany), GE Healthcare (US), Digital Diagnostics (US), Xilinx (US), InformAI (US), Enlitic (US), Day Zero Diagnostics (US), Aidence (Netherlands), Butterfly Network, Inc. (US), Prognos (US), Zebra Medical Vision (Israel), Viz.ai (US), Quibin (Spain), Qure.ai (India), Therapixel (France), and HeartFlow (US).


Research Coverage


This report studies the AI in medical diagnostics market based on component, end user, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.


Key Benefits of Buying the Report 


This report focuses on various levels of analysis - industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.


Frequently Asked Questions about the Artificial Intelligence (AI) in Medical Diagnostics Market

What is the estimated value of the Artificial Intelligence (AI) in Medical Diagnostics Market?

The Artificial Intelligence (AI) in Medical Diagnostics Market was estimated to be valued at $505.0 Million in 2020.

What is the growth rate of the Artificial Intelligence (AI) in Medical Diagnostics Market?

The growth rate of the Artificial Intelligence (AI) in Medical Diagnostics Market is 50.2%, with an estimated value of $3868.0 Million by 2025.

What is the forecasted size of the Artificial Intelligence (AI) in Medical Diagnostics Market?

The Artificial Intelligence (AI) in Medical Diagnostics Market is estimated to be worth $3868.0 Million by 2025.

Who are the key companies in the Artificial Intelligence (AI) in Medical Diagnostics Market?

Key companies in the Artificial Intelligence (AI) in Medical Diagnostics Market include Aidence, Butterfly Network, Inc., Day Zero Diagnostics, Digital Diagnostics (Formerly Known as Idx), Enlitic, GE Healthcare, Google (Subsidiary of Alphabet, Inc.), Heartflow and Informai.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aidence
  • Enlitic
  • IBM
  • Microsoft Corporation
  • Quibim
  • Therapixel

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Inclusions & Exclusions
1.3.1 Markets Covered
Figure 1 AI in Medical Diagnostics Market Segmentation
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders


2 Research Methodology
2.1 Research Data
2.2 Research Methodology Steps
Figure 2 Research Methodology: AI in Medical Diagnostics Market
Figure 3 Research Design
2.2.1 Secondary Data
2.2.1.1 Key Data from Secondary Sources
2.2.2 Primary Data
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Primary Sources
2.2.2.1 Key Data from Primary Sources
2.3 Market Size Estimation Methodology
Figure 6 Research Methodology: Hypothesis Building
Figure 7 Market Size Estimation
2.4 Market Data Estimation and Triangulation
Figure 8 Data Triangulation Methodology
2.5 Assumptions for the Study
2.6 COVID-19-Specific Assumptions


3 Executive Summary
Figure 9 AI in Medical Diagnostics Market, by Component, 2020 Vs. 2025 (USD Million)
Figure 10 AI in Medical Diagnostics Market, by Application, 2020 Vs. 2025 (USD Million)
Figure 11 AI in Medical Diagnostics Market, by End-user, 2020 Vs. 2025 (USD Million)
Figure 12 Geographical Snapshot of the AI in Medical Diagnostics Market


4 Premium Insights
4.1 AI in Medical Diagnostics Market Overview
Figure 13 Influx of Large and Complex Datasets in Healthcare to Drive Market Growth
4.2 North America: AI in Medical Diagnostics Market, by Application and Country (2019)
Figure 14 in Vivo Diagnostic Applications Segment Accounted for the Largest Share of the North American Market in 2019
4.3 AI in Medical Diagnostics Market Share, by Application, 2020 Vs. 2025
Figure 15 in Vivo Diagnostic Applications Segment Will Continue to Dominate the Market in 2025
4.4 AI in Medical Diagnostics Market: Geographic Growth Opportunities
Figure 16 APAC Market to Register the Highest Growth During the Forecast Period


5 Market Overview
5.1 Introduction
Figure 17 AI in Medical Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
5.1.1 Drivers
5.1.1.1 Influx of Large and Complex Datasets
5.1.1.2 Growing Number of Cross-Industry Partnerships and Collaborations
5.1.1.3 Increasing Demand for AI Tools in the Medical Imaging Field and Rising Focus on Reducing the Workload of Radiologists
5.1.1.4 Government Initiative to Increase the Adoption of AI-Based Technologies
5.1.1.5 Growth in Funding for AI-Based Start-Ups
5.1.2 Restraints
5.1.2.1 Reluctance Among Medical Practitioners to Adopt AI-Based Technologies
5.1.2.2 Lack of Skilled AI Workforce and Ambiguous Regulatory Guidelines for Medical Software
5.1.3 Opportunities
5.1.3.1 Untapped Emerging Markets
5.1.3.2 Growing Potential of AI-Technology in Imaging & Diagnostics to Fight COVID-19
5.1.3.3 Increasing Focus on Developing Human-Aware AI Systems
5.1.4 Challenges
5.1.4.1 Budgetary Constraints
5.1.4.2 Lack of Curated Healthcare Data
5.1.4.3 Concerns Regarding Data Privacy
Figure 18 Types of Healthcare Breaches Reported to the US Department of Health and Human Services (2018 to 2020)
5.1.4.4 Lack of Interoperability Between AI Solutions Offered by Different Vendors
5.2 Value Chain Analysis
Figure 19 AI in Medical Diagnostics Market: Value Chain Analysis
5.3 Case Studies
5.3.1 Focus on Improving Workflow Efficacy and Reducing the Burden on Radiologists
5.3.1.1 Use Case 1: Reducing the Burden on Radiologists by Developing and Testing An AI Model to Read Large Ultrasound Data
5.3.2 Improved Triage
5.3.2.1 Use Case 2: Precision Driven Health Developed Ml Model to Help Improve Work Triage of Cardiologists (2019)
5.4 Impact of COVID-19 on the AI in Medical Diagnostics Market
Figure 20 Pre- and Post-COVID-19 Impact Analysis
5.5 Ecosystem Coverage
Figure 21 AI in Medical Diagnostics Ecosystem
5.6 Technology Analysis
Table 1 Technological Developments by Leading Vendors
5.7 Regulations
5.7.1 Health Insurance Portability and Accountability Act of 1996 (Hipaa)
5.7.2 Health Information Technology for Economic and Clinical Health Act of 2009 (Hitech)
5.7.3 Consumer Privacy Protection Act of 2017
5.7.4 National Cybersecurity Protection Advancement Act of 2015
5.7.5 Future of Life Institute's Asilomar AI Principles
5.7.6 the European Medical Devices Regulation (Eu) 2017/745 and In-Vitro Diagnostic Medical Devices Regulation (Eu) 2017/746 in Combination with the General Data Protection Regulation 2016/679
5.7.7 the Cybersecurity Law of the People's Republic of China
5.8 Pricing Analysis


6 Artificial Intelligence in Medical Diagnostics Market, by Component
6.1 Introduction
Table 2 AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
6.1.1 Software
6.1.1.1 Software Segment to Witness Higher Growth During the Forecast Period
Table 3 AI in Medical Diagnostics Software Market, by Region, 2018-2025 (USD Million)
6.1.2 Services
6.1.2.1 Services Segment to Account for a Larger Share of the Market During the Forecast Period
Table 4 AI in Medical Diagnostics Services Market, by Region, 2018-2025 (USD Million)


7 Artificial Intelligence in Medical Diagnostics Market, by Application
7.1 Introduction
Table 5 AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
7.2 in Vivo Diagnostics
Table 6 AI in In Vivo Diagnostic Applications Market, by Region, 2018-2025 (USD Million)
7.2.1 in Vivo Diagnostic Applications Market, by Specialty
Table 7 AI in In Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
7.2.1.1 Radiology
7.2.1.1.1 AI-Based Diagnostic Tools Help Ease the Workflow of Radiologists
Table 8 AI in Radiology Market, by Region, 2018-2025 (USD Million)
7.2.1.2 Cardiology
7.2.1.2.1 Increased Complexity of Sudden Cardiac Diseases to Drive Market Growth
Table 9 AI in Cardiology Market, by Region, 2018-2025 (USD Million)
7.2.1.3 Neurology
7.2.1.3.1 Increased Start-Up Funding to Drive Market Growth
Table 10 AI in Neurology Market, by Region, 2018-2025 (USD Million)
7.2.1.4 Obstetrics/Gynecology
7.2.1.4.1 Rising Use of Minimally Invasive Techniques in Gynecology Procedures to Drive Market Growth
Table 11 AI in Obstetrics/Gynecology Market, by Region, 2018-2025 (USD Million)
7.2.1.5 Ophthalmology
7.2.1.5.1 Need for Early Detection and Prevention of Eye Diseases Driving the Adoption of AI-Based Diagnostic Tools
Table 12 AI in Ophthalmology Market, by Region, 2018-2025 (USD Million)
7.2.1.6 Other Specialties
Table 13 AI in Other Specialties Market, by Region, 2018-2025 (USD Million)
7.2.2 in Vivo Diagnostic Applications Market, by Modality
Table 14 AI in In Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
7.2.2.1 Computed Tomography
7.2.2.1.1 Need for Efficient Diagnosis Will Drive the Adoption of AI in Computed Tomography
Table 15 AI in Computed Tomography Market, by Region, 2018-2025 (USD Million)
7.2.2.2 X-Ray
7.2.2.2.1 Companies Such as Nvidia, Intel, and Xilinx Are Developing AI-Based Tools Exclusively in this Space
Table 16 AI in X-Ray Market, by Region, 2018-2025 (USD Million)
7.2.2.3 Magnetic Resonance Imaging
7.2.2.3.1 Increasing Burden of Brain-Related Disorders to Drive the Adoption of AI in Magnetic Resonance Imaging
Table 17 AI in Magnetic Resonance Imaging Market, by Region, 2018-2025 (USD Million)
7.2.2.4 Ultrasound
7.2.2.4.1 Increasing Prevalence of Ovarian Cancer and the Need for Its Early Diagnosis Will Drive Market Growth
Table 18 AI in Ultrasound Market, by Region, 2018-2025 (USD Million)
7.2.2.5 Other Modalities
Table 19 AI in Other Modalities Market, by Region, 2018-2025 (USD Million)
7.3 in Vitro Diagnostics
Table 20 AI in In Vitro Diagnostic Applications Market, by Region, 2018-2025 (USD Million)


8 Artificial Intelligence in Medical Diagnostics Market, by End-user
8.1 Introduction
Table 21 AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
8.2 Hospitals
8.2.1 Large Hospitals Have Been the Early Adopters of AI Solutions for Diagnostic Imaging
Table 22 AI in Medical Diagnostics Market for Hospitals, by Region, 2018-2025 (USD Million)
8.3 Diagnostic Imaging Centers
8.3.1 Increasing Number of Private Imaging Centers is Contributing to Market Growth
Table 23 AI in Medical Diagnostics Market for Diagnostic Imaging Centers, by Region, 2018-2025 (USD Million)
8.4 Diagnostic Laboratories
8.4.1 Increasing Specimen Test Volumes and Workload of Pathologists Has Boosted the Market Growth
Table 24 AI in Medical Diagnostics Market for Diagnostic Laboratories, by Region, 2018-2025 (USD Million)
8.5 Other End-users
Table 25 AI in Medical Diagnostics Market for Other End-users, by Region, 2018-2025 (USD Million)


9 Artificial Intelligence in Medical Diagnostics Market, by Region
9.1 Introduction
Table 26 AI in Medical Diagnostics Market, by Region, 2018-2025 (USD Million)
9.2 North America
Figure 22 North America: AI in Medical Diagnostics Market Snapshot
Table 27 North America: AI in Medical Diagnostics Market, by Country, 2018-2025 (USD Million)
Table 28 North America: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 29 North America: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 30 North America: in Vivo Diagnostic Applications Market,By Modality, 2018-2025 (USD Million)
Table 31 North America: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 32 North America: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.2.1 US
9.2.1.1 Increasing Volume of Imaging Procedures to Drive Market Growth in the US
Table 33 Us: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 34 Us: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 35 Us: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 36 Us: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 37 Us: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.2.2 Canada
9.2.2.1 Research Grants and Improved Academics in the Field of Radiology to Boost Market Growth in Canada
Table 38 Canada: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 39 Canada: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 40 Canada: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 41 Canada: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 42 Canada: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.3 Europe
Table 43 Europe: AI in Medical Diagnostics Market, by Country, 2018-2025 (USD Million)
Table 44 Europe: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 45 Europe: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 46 Europe: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 47 Europe: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 48 Europe: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.3.1 Germany
9.3.1.1 Government Initiatives to Expedite AI Development in Germany
Table 49 Germany: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 50 Germany: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 51 Germany: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 52 Germany: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 53 Germany: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.3.2 UK
9.3.2.1 Increasing Number of Radiography Procedures to Drive Market Growth in the UK
Table 54 Uk: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 55 Uk: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 56 Uk: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 57 Uk: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 58 Uk: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.3.3 France
9.3.3.1 Availability of Funding for Companies to Enhance AI Research in Medical Imaging
Table 59 France: AI in Medical Diagnostics Market, by Application,2018-2025 (USD Million)
Table 60 France: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 61 France: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 62 France: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 63 France: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.3.4 Rest of Europe
Table 64 RoE: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 65 RoE: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 66 RoE: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 67 RoE: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 68 RoE: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.4 Asia-Pacific
Figure 23 APAC: AI in Medical Diagnostics Market Snapshot
Table 69 APAC: AI in Medical Diagnostics Market, by Country, 2018-2025 (USD Million)
Table 70 APAC: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 71 APAC: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 72 APAC: in Vivo Diagnostic Applications Market, by Modality,2018-2025 (USD Million)
Table 73 APAC: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 74 APAC: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.4.1 China
9.4.1.1 China Dominated the APAC Market in 2019
Table 75 China: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 76 China: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 77 China: in Vivo Diagnostic Applications Market, by Modality,2018-2025 (USD Million)
Table 78 China: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 79 China: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.4.2 Japan
9.4.2.1 Presence of a Strong Infrastructure to Drive the Adoption of AI in Japan
Table 80 Japan: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 81 Japan: in Vivo Diagnostic Applications Market, by Specialty,2018-2025 (USD Million)
Table 82 Japan: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 83 Japan: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 84 Japan: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.4.3 India
9.4.3.1 Favorable Government Initiatives to Boost Market Growth in India
Table 85 India: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 86 India: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 87 India: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 88 India: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 89 India: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.4.4 Rest of Asia-Pacific
Table 90 Roapac: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 91 Roapac: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 92 Roapac: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 93 Roapac: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 94 Roapac: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.5 Rest of the World
Table 95 Row: AI in Medical Diagnostics Market, by Application, 2018-2025 (USD Million)
Table 96 Row: in Vivo Diagnostic Applications Market, by Specialty, 2018-2025 (USD Million)
Table 97 Row: in Vivo Diagnostic Applications Market, by Modality, 2018-2025 (USD Million)
Table 98 Row: AI in Medical Diagnostics Market, by Component, 2018-2025 (USD Million)
Table 99 Row: AI in Medical Diagnostics Market, by End-user, 2018-2025 (USD Million)


10 Competitive Landscape
10.1 Overview
Figure 24 Market Evaluation Framework, 2018-2021
10.2 Key Player Strategies
10.3 Ranking of Players, 2019
Figure 25 Ranking of Key Companies in the AI in Medical Diagnostics Market (2019)
10.4 Competitive Leadership Mapping
10.4.1 Stars
10.4.2 Emerging Leaders
10.4.3 Pervasive Players
10.4.4 Participants
Figure 26 AI in Medical Diagnostics Market: Competitive Leadership Mapping (2019)
10.5 Competitive Leadership Mapping (Start-Ups)
10.5.1 Progressive Companies
10.5.2 Dynamic Companies
10.5.3 Responsive Companies
10.5.4 Starting Blocks
Figure 27 AI in Medical Diagnostics Market (Start-Ups): Competitive Leadership Mapping (2019)
10.6 Company Product Footprint
Table 100 Footprint of Companies
Table 101 Application Footprint of Companies
Table 102 Regional Footprint of Companies
10.7 Competitive Scenario
Table 103 AI in Medical Diagnostics Market: Product Launches, 2018-2021
Table 104 AI in Medical Diagnostics Market: Deals, 2018-2021
Table 105 AI in Medical Diagnostics Market: Other Developments, 2018-2021


11 Company Profiles
11.1 Major Players
(Business Overview, Products Offered, Recent Developments, Analyst's View)*
11.1.1 Microsoft Corporation
Table 106 Microsoft Corporation: Business Overview
Figure 28 Microsoft Corporation: Company Snapshot
Table 107 Microsoft Corporation: Products Offered
11.1.2 Nvidia
Table 108 Nvidia: Business Overview
Figure 29 Nvidia: Company Snapshot
Table 109 Nvidia: Products Offered
11.1.3 Ibm
Table 110 Ibm: Business Overview
Figure 30 Ibm: Company Snapshot
Table 111 Ibm: Products Offered
11.1.4 Intel
Table 112 Intel: Business Overview
Figure 31 Intel: Company Snapshot
Table 113 Intel: Products Offered
11.1.5 Google (Subsidiary of Alphabet, Inc.)
Table 114 Google: Business Overview
Figure 32 Google: Company Snapshot
Table 115 Google: Products Offered
11.1.6 Siemens Healthineers
Table 116 Siemens Healthineers: Business Overview
Figure 33 Siemens Healthineers: Company Snapshot
Table 117 Siemens Healthineers: Products Offered
11.1.7 GE Healthcare
Table 118 GE Healthcare: Business Overview
Figure 34 GE Healthcare: Company Snapshot
Table 119 GE Healthcare: Products Offered
11.2 Other Players
11.2.1 Digital Diagnostics (Formerly Known as Idx)
Table 120 Digital Diagnostics: Business Overview
Table 121 Digital Diagnostics: Products Offered
11.2.2 Xilinx
Table 122 Xilinx: Business Overview
Figure 35 Xilinx: Company Snapshot
Table 123 Xilinx: Products Offered
11.2.3 Informai
Table 124 Informai: Business Overview
Table 125 Infromai: Products Offered
11.2.4 Heartflow
Table 126 Heartflow: Business Overview
Table 127 Heartflow: Products Offered
11.2.5 Enlitic
Table 128 Enlitic: Business Overview
Table 129 Enlitic: Products Offered
11.2.6 Day Zero Diagnostics
Table 130 Day Zero Diagnostics: Business Overview
11.2.6.2 Products Offered
Table 131 Day Zero Diagnostics: Products Offered
11.2.7 Aidence
Table 132 Aidence: Business Overview
Table 133 Aidence: Products Offered
11.2.8 Butterfly Network, Inc.
Table 134 Butterfly Network: Business Overview
Table 135 Butterfly Network: Products Offered
11.2.9 Prognos
Table 136 Prognos: Business Overview
Table 137 Prognos: Products Offered
11.2.10 Zebra Medical Vision
Table 138 Zebra Medical Vision: Business Overview
Table 139 Zebra Medical Vision: Products Offered
11.2.11 Viz.AI
Table 140 Viz.AI: Business Overview
Table 141 Viz.AI: Products Offered
11.2.12 Quibim
Table 142 Quibim: Business Overview
Table 143 Quibim: Products Offered
11.2.13 Qure.AI
Table 144 Qure.AI: Business Overview
Table 145 Qure.AI: Products Offered
11.2.14 Therapixel
Table 146 Therapixel: Business Overview
Table 147 Therapixel: Products Offered
*Business Overview, Products Offered, Recent Developments, Analyst's View Might Not be Captured in Case of Unlisted Companies.


12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: The Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details


Note: Product cover images may vary from those shown
  • Aidence
  • Butterfly Network, Inc.
  • Day Zero Diagnostics
  • Digital Diagnostics (Formerly Known as Idx)
  • Enlitic
  • GE Healthcare
  • Google (Subsidiary of Alphabet, Inc.)
  • Heartflow
  • IBM
  • Informai
  • Intel
  • Microsoft Corporation
  • Nvidia
  • Prognos
  • Quibim
  • Qure.AI
  • Siemens Healthineers
  • Therapixel
  • Viz.AI
  • Xilinx
  • Zebra Medical Vision
Note: Product cover images may vary from those shown

Loading
LOADING...